Naxitamab-gqgk Injection

Anter

• Ma mua o ka loaʻa ʻana o ka naxitamab-gqgk,
• Naxitamab-gqgk e hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Naxitamab-gqgk injection hiki ke hana i nā hopena koʻikoʻi a hoʻoweliweli paha i ke ola. E nānā pono ana kahi kauka a kahu hānai paha iā ʻoe a i ʻole ʻo kāu keiki i ka loaʻa ʻana o ka infusion a no 2 mau hola ma hope e hāʻawi i ka lapaʻau inā he hopena koʻikoʻi i ka lāʻau. Hāʻawi ʻia ʻoe i nā lāʻau ʻē aʻe ma mua a i ka wā o ka naxitamab-gqgk e pale a mālama ai i nā hopena infusion. E haʻi koke i kāu kauka inā ʻike ʻoe i kekahi o nā ʻōuli i lalo i ka wā o kāu infusion a ma hope paha o kāu infusion: hives; ʻehu; ʻumeʻume; ʻulaʻula o ka ʻili; kuni; haʻalulu; hū a paʻakikī paha i ka hanu ʻana a me ka ale ʻana paha; pehu o ka maka, ʻāʻī, elelo, a mau lehelehe paha; puʻupuʻu, uila, a maule paha; aiʻole kahi puʻuwai wikiwiki.

Naxitamab-gqgk injection hiki ke hōʻeha i nā aʻa i hopena i ka ʻeha a i ʻole nā ​​hōʻailona ʻē aʻe. Loaʻa iā ʻoe a i ʻole paha i kāu keiki ka lāʻau ʻeha ma mua, i ka wā, a ma hope o ka naxitamab-gqgk infusion. E haʻi koke i kāu kauka a i ʻole nā ​​mea lawelawe olakino ʻē aʻe inā ʻike ʻoe a i ʻole paha i kāu keiki i kekahi o nā ʻōuli ma hope a i ka wā o ka infusion: ʻeha nui a i ʻole ʻeha hoʻi, ʻeha hoʻi i ka ʻōpū, kua, umauma, nāʻiʻo a i ʻole nā ​​ami. numbness, tingling, burn, a nāwaliwali paha i nā wāwae a i ʻole nā ​​lima; pilikia i ka urino a i ʻole ka hoʻonele ʻana i kāu ʻōpū; ʻeha poʻo; ʻike maka ʻole, hoʻololi i ka hihiʻo, ka nui o nā haumāna, ʻoi aku ka paʻakikī i ka nānā ʻana, a i ʻole ka ʻike i ka malamalama. huikau a hōʻemi paha i ka makaʻala; paʻakikī e ʻōlelo; aiʻole ka hopu ʻana.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Ke alakaʻi lāʻau) ke hoʻomaka ʻoe i ka lāʻau me ka naxitamab-gqgk a i kēlā me kēia manawa e hoʻopiha hou i kāu kauka. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

E kamaʻilio me kāu kauka e pili ana i ka makaʻu (s) o ka loaʻa ʻana o ka naxitamab-gqgk.

Hoʻohana ʻia ka naxitamab-gqgk injection me ka lāʻau lapaʻau ʻē aʻe i nā mākua a me nā keiki he 1 mau makahiki a ʻoi aku ka nui e mālama ai i ka neuroblastoma (kahi maʻi ʻaʻa e hoʻomaka i nā pūnana nerve) i ka iwi a i ʻole ka iwi o ka iwi i hoʻi mai a i ʻole i pane i kahi mea i hala. lapaʻau, akā ʻo wai ka mea i pane i nā ʻano lāʻau ʻē aʻe. Aia ka Naxitamab-gqgk injection i kahi papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ka luku ʻana i nā hunaola maʻi ʻaʻai.

Hele mai ʻo Naxitamab-gqgk ma ke ʻano he hopena (wai) e ʻimi ʻino ʻia (i loko o kahi aa) ma mua o 30 a 60 mau minuke e ke kauka a kahu wahine paha i kahi keʻena lapaʻau a i ʻole ke kikowaena infusion. Hāʻawi pinepine ʻia ia i nā lā 1, 3, a me 5 o kahi pōʻaiapuni 28 lā a e hana hou ʻia paha ia ma muli o kāu pane. Ma hope o ka hana mua ʻana, hiki i kāu kauka ke kuhikuhi i nā pōʻai hoʻomaikaʻi hou aʻe i kēlā me kēia 8 pule.

E mālama paha kāu kauka iā ʻoe me nā lāʻau ʻē aʻe ma mua a i kēlā me kēia kau ʻana e kōkua ai i ka pale ʻana i nā hopena ʻaoʻao. Pono paha kāu kauka e hoʻopau i kahi manawa a kūpaʻa mau paha i kāu lāʻau a hōʻemi paha i kāu lāʻau o naxitamab-gqgk i kāu wā e lapaʻau ai. Aia kēia i ka maikaʻi o ka hana ʻana o ka lāʻau iā ʻoe a me nā hopena ʻē aʻe āu e ʻike ai. E pono e haʻi aku i kāu kauka i kou ʻano i kou wā e mālama ai me ka naxitamab-gqgk.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka naxitamab-gqgk,

• e haʻi aku i kāu kauka a me ka kauka inā he maʻi ʻoe i ka naxitamab-gqgk, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka naxitamab-gqgk injection. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa i ka hypertension a i ʻole ka paʻa ʻana o ka urinary (hiki ʻole i ka mimi).
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. Pono ʻoe e lawe i kahi hōʻike hāpai ma mua o ka hoʻomaka ʻana i ka lāʻau. Pono ʻoe e hoʻohana i ka kaohi hānau kūpono i kāu mālama ʻana a no 2 mau mahina ma hope o kāu hopena hope loa. Inā hāpai ʻoe i ka loaʻa ʻana o ka naxitamab-gqgk, e kāhea i kāu kauka. Hoʻopilikia paha ʻo Naxitamab-gqgk i ka ʻōpū.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū. ʻAʻole pono ʻoe e hānai i ka wā o kāu mālama ʻana me ka naxitamab-gqgk a no 2 mau mahina ma hope o kāu hopena hope loa.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai ka naxitamab-gqgk, e kāhea koke i kāu kauka.

Naxitamab-gqgk e hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ka luaʻi
• nausea
• pāhoehoe
• nalo ʻai ʻole
• hopohopo
• luhi
• ka ʻū, ka ihu ihu, ke kuni, a i ʻole nā ​​hōʻailona ʻē aʻe o ka maʻi

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• ʻeha poʻo poʻo, heihei a i ʻole pākuʻi puʻuwai ʻole, ʻeha o ka umauma, puʻupuʻu, hanu, hanu ke ihu, a luhi paha.

Hoʻokumu paha ʻo Naxitamab-gqgk i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E nānā kāu kauka i kou kaomi koko i kekahi mau manawa i kāu pōʻaiapuni a kauoha i kekahi mau hoʻokolohua e nānā i ka pane o kou kino i ka naxitamab-gqgk.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Danyelza^®